420 with CNW — Federally Funded Survey Finds Significant

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
291
420 with CNW — Federally Funded Survey Finds Significant Decline in Cannabis Use Among Youths

A new survey has found that the use of cannabis by youths reduced considerably this year. The Monitoring the Future survey was funded by the National Institute on Drug Abuse. It has been tracking adolescent attitudes towards drugs and drug behavior since 1975.

The self-reporting survey was taken by more than 32,000 students from 319 schools who completed it between February and June of this year. Its latest results show a significant decline in marijuana use among 8th, 10th and 12 graders in 2021. This is despite the fact that more laws to legalize marijuana are being enacted and implemented in various states across the country.

The survey’s findings show that in comparison to more than11% of 8th graders who reported that they used cannabis last year, only 7.1% did so this year. In 10th graders, this percentage dropped to 17.2% from the 28% recorded last year while in 12th graders, the number dropped to 30% this year, from the 35.3% recorded last year. This data offers evidence that supports the argument that legalizing cannabis for adults doesn’t lead to a rise in underage drug usage.

The survey, which was carried out by researchers at the University of Michigan, also found that the daily, 30-day and lifetime use of marijuana among adolescents also declined this year. A decline was also observed in the use of nicotine vaping, alcohol and other illicit drugs. However, the researchers note that the decline observed in past-year marijuana use is especially steep when compared to the consumption of all other illicit substances.

In a press release, National Institute on Drug Abuse director Nora Volkow stated that the agency had never observed such a huge decline in the use of drugs among teens in a one-year period, adding that the data highlighted an unforeseen consequence of the coronavirus pandemic, which caused tremendous shifts in the daily lives of adolescents. She noted that the agency was now focused on identifying the central elements of last year that contributed to the decline in drug usage in order to use it to inform future prevention efforts.

In a separate press release, the deputy director of NORML, Paul Armentano, stated that the survey’s findings added to scientific literature showing that cannabis regulation policies could be implemented in a manner that afforded grownups access while simultaneously limiting youth misuse and access. The National Organization for the Reform of Marijuana Laws (“NORML”) is a not-for-profit organization that advocates for the reform of cannabis laws for both recreational and medical use in the United States.

It is gratifying to find that states that have legalized the activities of licensed marijuana companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) are contributing to reducing the rates at which underage marijuana use takes place.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer


Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links

NUGS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 34

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 36

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 62

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 47

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 45

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Mixed Markets: Analyzing Germany's Stock Performance

Updated Category News Views 211

Markets in Germany Prepare for Fluctuations As trading wrapped up on Wednesday, the German stock market exhibited a mixed bag of results. While certain sectors, such as Food & Beverages, Media, and Financial Services, reported gains, others faced setbacks. The Consumer & Cyclical, Construction, and Pharmaceuticals & Healthcare sectors saw declines, reflecting the market's...

Continue Reading
Teradyne's Q3 Earnings: Strong Performance and Future Growth Potential

Updated Category News Views 176

Teradyne's Q3 Earnings Exceed Expectations Teradyne Incorporated (NASDAQ: TER), a prominent player in automated test equipment, has released its third-quarter results, building a narrative of success and optimism. The company reported impressive sales figures of $737 million, with non-GAAP earnings per share (EPS) reaching $0.90, bolstered by a solid gross margin of...

Continue Reading
So-Young Plans to Revise ADS Ratio for Improved Trading

Updated Category News Views 163

So-Young's Strategic Shift in ADS Ratio So-Young International Inc. (NASDAQ: SY), a leading aesthetic treatment platform, has recently announced plans to change the ratio of its American depositary shares (ADSs) to Class A ordinary shares. This strategic decision aims to refine its trading dynamics, enhancing value for its shareholders. Details of the ADS Ratio Change The...

Continue Reading
Understanding Recent Developments at GitLab: Investor Insights

Updated Category News Views 78

Contextual Overview of GitLab's Recent Investor Challenges In a rapidly evolving technological landscape, GitLab Inc. stands at a critical juncture as investors navigate its latest developments and challenges. Recent announcements regarding financial performance have sparked interest and concern among stakeholders. Understanding the implications of these changes is...

Continue Reading
Celebrating 15 Years of Transformative Care at Senderra Pharmacy

Updated Category News Views 273

15 Years of Innovation in Specialty Pharmacy Senderra Specialty Pharmacy has proudly reached a remarkable milestone—15 years of providing top-tier healthcare solutions in the specialty pharmacy sector. This anniversary embodies a journey marked by significant advancements and unwavering commitment to revolutionizing patient care. Transforming Patient Experiences Since...

Continue Reading